The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls
Every recall we track for The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — 24 in all, from 2023–2025 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls per year, by danger level
Recalls from The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories more than tripled in 2025 (15, up from 5 in 2024). 4% rated “stop using now”.
All FDA recall records for The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 3 | 1 | 4 |
| 2024 | 0 | 0 | 3 | 2 | 5 |
| 2025 | 1 | 0 | 6 | 8 | 15 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Most common reasons for The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls
What to do if you have a recalled The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls
15 shown- UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and
Major Pharmaceuticals recalls 200mg chlorpromazine tablets due to potential presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. This may pose health risks with improper use. Contact for return instructions.
Major PharmaceuticalsSep 12, 2025 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per
Major Pharmaceuticals recalls 10-tablet sulfamethoxazole-trimethoprim packs with a foreign microorganism in packaging. No tablets were contaminated. Consumers should check product details and contact the manufacturer for guidance.
Major PharmaceuticalsSep 2, 2025 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major
Major Pharmaceuticals recalls 12.5 mg Carvedilol Tablets due to NNCI impurity exceeding FDA limits. Affected units may pose health risks; contact for return instructions.
Major PharmaceuticalsAug 20, 2025 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and
Major Pharmaceuticals recalls 10mg ChlorproMAZINE Hydrochloride Tablets with N-Nitroso-Desmethyl Chlorpromazine impurity above safety limits. Rx-only medication distributed in cartons of 100 tablets.
Major PharmaceuticalsApr 14, 2025 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and
Major Pharmaceuticals recalls 2mg Tolterodine Extended-Release Capsules due to failed dissolution testing in stability checks. This may affect medication effectiveness. Check your NDC 0904-6592-04 lot numbers.
Major PharmaceuticalsMar 4, 2025 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters),
Major Pharmaceuticals recalls Potassium Chloride Extended-Release Tablets due to failed dissolution specifications. This could affect medication effectiveness. Check your product details and contact the manufacturer for instructions.
Major PharmaceuticalsJan 30, 2025 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product
Major Pharmaceuticals recalls Lorazepam 0.5mg tablets due to failed impurities and sub-potent drug results from stability testing. These tablets may not contain the correct amount of active ingredient. Consumers should contact the manufacturer for details.
Major PharmaceuticalsJan 21, 2025 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and
Major Pharmaceuticals recalls 20mg Duloxetine capsules due to potential nitrosamine impurities. This could pose health risks if consumed. Affected lots: N01530 (exp 01/2025) and N01540 (exp 01/2025).
Major PharmaceuticalsJan 13, 2025 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100,
Major Pharmaceuticals recalls certain Guaifenesin Dextromethorphan Syrup due to failed impurity specifications. Consumers should check product labels for lot numbers and expiration dates.
Major PharmaceuticalsNov 7, 2024 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East
Major Pharmaceuticals recalls 25mg Hydralazine HCl tablets due to impurities detected during stability testing. Affected lots expire by 12/2024 and 07/2025. Consumers should check their lot numbers and contact the manufacturer for details.
Major PharmaceuticalsNov 5, 2024 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by:
Major Pharmaceuticals recalls 37.5mg Venlafaxine Hydrochloride extended-release capsules due to failed dissolution testing during stability checks. This medication is prescription-only and may not release properly in the body.
Major PharmaceuticalsJun 18, 2024 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls HydrALAZINE Hydrochloride Tablets, USP 10mg, packaged in 100-count (10x10 blister cards), Lot T04680, Rx only,
Major Pharmaceuticals recalls HydrALAZINE Hydrochloride 10mg tablets (Lot T04680) due to a remote possibility of temporary health effects from impurities. No immediate action needed as the risk is low.
Major PharmaceuticalsFeb 9, 2024 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Dist. by: RUGBY LABORATORIES,
Major Pharmaceuticals recalls Polyvinyl Alcohol 1.4% lubricating eye drops due to non-sterility risks from manufacturing facility contamination. All bottles are affected.
Major PharmaceuticalsOct 31, 2023 - Lower riskDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Phenytoin Oral Suspension, USP, 100 mg/4 mL, packaged in packaged in 4 mL unit dose cups (NDC 0904-7079-24), 50 per
Major Pharmaceuticals recalls Phenytoin Oral Suspension due to failed content uniformity specifications. This may affect medication dosing accuracy. Contact for remedy details.
Major PharmaceuticalsOct 23, 2023 - UnratedDrug
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg, Unit Dose Carton 40 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories
Major Pharmaceuticals recalls 20mg Ziprasidone capsules due to label mix-up with Dronabinol capsules. Affected units contain incorrect medication. Consumers should check product details and contact for guidance.
Major PharmaceuticalsMay 31, 2023
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall questions
How many recalls has The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories had?
24 recalls from The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories are on record with U.S. safety agencies, from 2023–2025.
What is the most recent The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall?
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Major ChlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and, dated Sep 12, 2025. Every The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recall is listed on this page, newest first.
Why are The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories products recalled?
The most common reasons on record: Failed Impurity/Degradation Specifications (2).
What should I do if I have a recalled The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.